ALHC

Alignment Healthcare is expected to report a quarterly loss of $0.04 per share with revenues up 31.9% year-over-year for Q3 2026. The company has a negative Earnings ESP of -37.50% and a Zacks Rank of #4 (Sell), making it unlikely to beat consensus estimates. However, the company has beaten EPS estimates in all four of the last quarters.

A securities fraud investigation into Alignment Healthcare continues following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances by misclassifying operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.

A whistleblower lawsuit alleges that Alignment Healthcare manipulated its finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA and report false positive earnings. The stock fell 16.7% on the news, injuring investors.

Alignment Healthcare's stock plummeted 59% between July and October 2026 after CMS downgraded its California HMO plan (H3815) from 4.0 to 3.5 Star Rating, making it ineligible for quality bonus payments. The company faces investor scrutiny over allegedly misleading statements about its confidence in maintaining bonus eligibility, with management refusing to discuss Star Rating positioning in September before the downgrade was publicly disclosed.

CVS Health and Alignment Healthcare are competing in the fast-growing Medicare Advantage market, projected to expand at 10.1% CAGR through 2034. CVS is successfully turning around Aetna with over $2 billion in adjusted operating income gains in H1 2026, while Alignment Healthcare grew membership 31.5% but faces headwinds from higher medical needs among new members. CVS trades at a lower forward P/E (10.41 vs 25.43) with positive earnings revisions, while Alignment faces downward estimate revisions and a 50.8% stock decline over the past year.

Options traders are pricing in significant volatility for Alignment Healthcare (ALHC) based on high implied volatility in January 2027 $22.50 calls. However, the fundamental outlook is weak, with the company holding a Zacks Rank #4 (Sell) rating.

Analysts have downgraded earnings estimates over the past 60 days, with consensus estimates moving from +$0.01 to -$0.03 per share. The high implied volatility may indicate traders are positioning to sell premium and profit from expected decay rather than directional movement.

Alignment Health Plan announced a new Medicare Advantage plan for Pima County effective January 1, 2027, expanding its Arizona portfolio to seven plans across three counties serving nearly 1.1 million Medicare beneficiaries. The expansion includes Alignment Health ONE (HMO) and Alignment Health UNICO with bilingual support, low out-of-pocket limits, and additional benefits. Alignment's Arizona HMO contract received a 4-star rating for 2027.

Alignment Health Plan announced expansion into Nye County effective January 1, 2027, extending its Medicare Advantage coverage across three Nevada counties (Clark, Nye, and Washoe) serving over 554,000 Medicare beneficiaries. The 2027 portfolio includes six plans with partnerships including Intermountain Health and Instacart, featuring 4 to 4.5-star ratings and various benefits such as grocery allowances and reduced Medicare Part B premiums.

Alignment Health Plan announced a provider arrangement with Astrana Health to expand in-network access to primary and specialty care for Medicare Advantage beneficiaries across seven California counties (Los Angeles, Orange, Riverside, San Bernardino, San Francisco, San Mateo, and Santa Clara) beginning January 1, 2027. The collaboration will provide members access to Astrana's network of 3,000 primary care providers and 6,500 specialists, with emphasis on multilingual and culturally responsive care for California's diverse senior population.

Alignment Health Plan announced expansion into Bexar and Comal counties in Texas effective January 1, 2027, bringing Medicare Advantage coverage to over 392,000 beneficiaries in the San Antonio region. The expansion marks the company's second Texas market after El Paso, creating a portfolio of 10 Medicare Advantage plans with partnerships including Baptist Health System. The 2027 Texas HMO contract earned a 4.5 out of 5-star rating from CMS.

Alignment Health Plan announced the launch of Central Health Harmony, a new Medicare Advantage plan tailored for Asian American seniors in Los Angeles and Orange counties, effective January 1, 2027. The plan features access to over 600 Chinese-, Korean-, and Vietnamese-speaking physicians, culturally tailored benefits including enhanced acupuncture coverage, in-language support, and grocery allowances at Asian specialty markets. The plan partners with leading providers including Astrana Health and Hoag Health System.

Alignment Health Plan announced expansion into Kern, Kings, and Tulare counties in California's Central Valley and added Hoag and Astrana Health to its provider network for 2027. The expansion will bring coverage to 25 California counties serving over 6.3 million Medicare beneficiaries, with 46 Medicare Advantage plans offering premiums as low as $0 and specialized plans for chronic conditions.